Evidence map›Paper›PMID 42293811›Full record

ArticleInternational journal of dentistry2026

Preliminary In Vitro Evaluation of Vitamin E (α-Tocopherol) Incorporation on Cytotoxicity, Antifungal Activity, and Surface Roughness of Denture Acrylic Soft Liner.

Neven S Aref

Abstract read
In one paragraph

Article in International journal of dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Neven S ArefDepartment of Basic Oral Sciences and Dental Education, College of Dentistry, Qassim University, Buraydah, Saudi Arabia, qu.edu.sa.ORCID https://orcid.org/0000-0002-5241-2838

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Denture soft liners are widely used in prosthodontics to improve patient comfort by cushioning the interface between the denture base and oral mucosa. However, clinical durability can be compromised by elevated surface roughness and adverse biological responses, including cytotoxicity and fungal colonization. Antioxidant supplementation-particularly with vitamin E (α-tocopherol)-has been proposed as a strategy to enhance both the biocompatibility and surface quality of these materials. Materials and Methods: A commercially available chairside acrylic soft liner was modified with vitamin E at concentrations of 0.1, 0.2, and 0.5 wt.%, alongside an unmodified control group. Cytotoxicity was evaluated using the MTT cell viability assay on Vero cells, antifungal activity against Results: Vitamin E incorporation produced a statistically significant, concentration-dependent effect on both cell viability and surface roughness. The 0.2 wt.% group demonstrated the highest cell viability (48.0 ± 6.1%) and the lowest surface roughness (2.80 ± 0.23 µm) among all groups. Cell viability declined at 0.5 wt.%, yet remained significantly higher than the unmodified control. No antifungal inhibition zones were detected in any vitamin E-modified group. Conclusions: Vitamin E incorporation improved selected biological and surface characteristics of the tested acrylic denture soft liner in a concentration-dependent manner. The 0.2 wt.% formulation demonstrated the most favorable in vitro performance among the tested groups. However, these findings are preliminary, and comprehensive mechanical and physical evaluation is required before any clinical relevance or application can be established.

Indexed as

acrylic soft linerantifungal activitycytotoxicitydenture biocompatibilitysurface roughnessvitamin Eα-tocopherol

Identifiers

PMID42293811
PMCPMC13254811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.